 Shares of Autolus Therapeutics plc NASDAQ: AUTL jumped about 30 in premarket trading on Monday after it said Blackstone Life Sciences agreed to invest up to 250 million to fund the development of its new therapy for Leukemia. Blackstone is taking a sizable equity stake in Autolus Blackstone is taking an equity stake worth 100 ... The post Blackstone triggers a 30 increase in Autolus Therapeutics shares appeared first on Invezz. 